ArticlePsychiatry and clinical psychopharmacology2021
Evaluation of Depression with Mixed Features and Bipolarity Screening in Patients with Epilepsy.
Article in Psychiatry and clinical psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate depression with mixed features (MXD) and risk of bipolarity and to explore the association between clinical variables in patients with epilepsy. Materials and Methods: A total of 62 patients who were followed up with epilepsy diagnosis at least 2 years were enrolled. Demographic and clinical data were collected using face to face interview. All subjects also performed modified hypomania checklist (mHCL), Beck depression inventory (BDI), and the mood disorder questionnaire (MDQ). Results: According to the BDI, 25 (40.3%) of the cases required additional psychiatric examination for depression. MDQ scores indicated that 7 (9.7%) of the cases required additional psychiatric evaluation for bipolar disorder. Due to the mHCL assessment, 20 (32.2%) cases had at least 3 manic symptoms, and 9 (14.5%) cases had at least 13 manic symptoms of mixed depression. A significant positive correlation was found between the scores of BDI and mHCL ( Conclusion: Our results suggest that MXD is more common and the risk of bipolarity is higher in patients with epilepsy. Therefore, clinical assessment of MXD is substantial for determining bipolarity in epileptic individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.